secwatch.observer — SEC 8-K summary
======================================

Issuer:     Shuttle Pharmaceuticals Holdings, Inc. (SHPH)
CIK:        0001757499
Form:       8-K
Filed at:   2026-02-02T23:59:59+00:00
Accession:  0001493152-26-004782
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shuttle extends interim CEO Cooper's consulting agreement through August 1, 2026
--------------------------------------------------------------------------------

- Extended consulting agreement with Number 2 Capital Corp. (owned by interim co-CEO Cooper) to August 1, 2026.
- Monthly compensation unchanged at $20,000; 40-hour work week.
- Amendment effective retroactively to September 11, 2025.
- Agreement can be terminated by either party upon 30 days' notice.
- Standard confidentiality and non-disclosure provisions included.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226004782/0001493152-26-004782-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1757499/000149315226004782/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-004782

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer